Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolio

Smith+Nephew has signed a distribution agreement with SI-BONE for the iFuse TORQ pelvic fracture fixation portfolio.

The agreement is intended to broaden Smith+Nephew’s offerings for percutaneous pelvic fracture fixation procedures and to enhance its position in trauma care involving high-impact, high-frequency cases.

The iFuse TORQ portfolio includes the iFuse TORQ TNT and iFuse TORQ implants. These devices are indicated for pelvic fracture fixation and sacroiliac (SI) joint fusion.

iFuse TORQ TNT is designed to address bone density and anatomical requirements of the ilium and sacrum specifically.

The technology behind iFuse TORQ TNT has received the US Food and Drug Administration (FDA) breakthrough device designation for its potential to offer more effective treatment of pelvic fractures than traditional cannulated screws.

Additionally, it qualifies for a Medicare New Technology Add-on Payment (NTAP), providing hospitals with up to $4,136 in extra reimbursement per procedure using this device.

Through this agreement, Smith+Nephew accesses the broader iFuse TORQ product line with SI-BONE’s existing sales channel. This move aims to better serve surgeons and patients in need of advanced pelvic fracture fixation options.

Smith+Nephew trauma, extremities and shoulder vice-president Scott Gunn said: “We’re incredibly excited to partner with SI-BONE. This collaboration reflects a shared commitment to innovation, clinical excellence, and improving patient outcomes.

“By combining SI-BONE’s industry leadership with Smith+Nephew’s established commercial platform, we see a meaningful opportunity to expand access to differentiated solutions, deepen surgeon engagement, and drive sustainable growth.”

Earlier this year, Smith+Nephew agreed to acquire Integrity Orthopaedics, a US-based developer of the Tendon Seam rotator cuff repair (RCR) system, for up to $450m.

Under the agreement, Smith+Nephew purchased Integrity Orthopaedics for an upfront cash payment of $225m, with additional performance-linked payments of up to $225m scheduled over the following five years.

Unlock up to 35% savings on GlobalData reports

Use the code at checkout in the report store

• 20% OFF

  Buy 2 reports

  Use code:

  Bundle20

• 25% OFF

  Buy 3 reports

  Use code:

  Bundle25

• 30% OFF

  Buy 4 reports

  Use code:

  Bundle30

• 35% OFF

  Buy 5+ reports

  Use code:

  Bundle35

Valid on all reports priced $995 and above. Cannot be combined with other offers.

Still deciding what will work best for your business?

Ask our experts for help.

Enquire before buying